Nothing Special   »   [go: up one dir, main page]

Maini et al., 1976 - Google Patents

Is the clinical benefit from transfer factor in rheumatoid arthritis a placebo effect?

Maini et al., 1976

Document ID
13403516364191401898
Author
Maini R
Scott J
Hamblin A
Roffe L
Dumonde D
Publication year
Publication venue
Transfer Factor

External Links

Snippet

Summary and introduction In a cross-over study of blood bank dialysable leucocyte transfer factor (TF) in rheumatoid arthritis, we found that beneficial effects that were observed in 3 patients, and which occurred in the first 3 weeks, were entirely comparable to the placebo …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Similar Documents

Publication Publication Date Title
DiSciascio et al. Rheumatic fever in children
Bullock et al. An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy
de los Angeles Pineda et al. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis
Swanson et al. Immunosuppressive therapy: the relation between clinical response and immunologic competence
Bullock Jr et al. Studies of immune mechanisms in leprosy: III. The role of cellular and humoral factors in impairment of the in vitro immune response
Lamb et al. A comparative study of the incidence of anergy in patients with carcinoma, leukemia, Hodgkin's disease and other lymphomas
Geefhuysen et al. Impaired cellular immunity in kwashiorkor with improvement after therapy
MCLRVINE et al. Depressed Immune Response in Burn Patients: Use of Monoclonal Anitbodies and functional Assays to Define the Role of Suppressor Cells
Cornick et al. Escherichia coli O157: H7 infections: discordance between filterable fecal Shiga toxin and disease outcome
Keller Weight gain impacts morbidity and mortality in institutionalized older persons
Steele Managing infection in cancer patients and other immunocompromised children
Simon et al. Ampicillin in the treatment of chronic typhoid carriers: report on fifteen treated cases and a review of the literature
Voulgari et al. Infliximab therapy in established rheumatoid arthritis: an observational study
Sindher et al. Increases in plasma IgG4/IgE with trilipid versus paraffin/petrolatum-based emollients for dry skin/eczema
Rieder Tuberculosis in an Indochinese refugee camp: epidemiology, management and therapeutic results
Schaffner et al. Clinical epidemiology of sporadic measles in a highly immunized population
Maini et al. Is the clinical benefit from transfer factor in rheumatoid arthritis a placebo effect?
Spencer et al. Tuberculosis surveillance in a state prison system.
Rengarajan et al. Immunological status of patients of Eales' disease
McRipley et al. The role of the phagocyte in host-parasite interactions: V. Phagocytic and bactericidal activities of leukocytes from patients with different neoplastic disorders
Cooper et al. Complement in normal and disease processes
ADAMS et al. Reversal of tuberculin reaction in early tuberculosis
Lee et al. Measurement of antibody-producing capacity to flagellin in man. IV. Studies in autoimmune disease, allergy and after azathioprine treatment
Catanzaro et al. Clinical and immunologic results of transfer factor therapy in coccidioidomycosis
Ekstedt et al. Runt diseases induced by non-living bacterial antigens